Wednesday World News Round Up @ The Hemp Club

It’s a big week for Germany’s medical marijuana market, which received its first cannabis imports from Australia and Portugal. Frankfurt-based Cansativa took delivery of medical cannabis oils for testing purposes from Western Australia-based Little Green Pharma.

Kentucky Senator Mitch McConnell (R), a chief proponent of a hemp legalization provision in the 2018 Farm Bill, has put the pressure on the Food and Drug Administration (FDA) to expedite the path for lawful marketing of hemp-derived CBD products. 

Excessive state regulations may be the reason illegal marijuana markets continue to exist after legalization, a new exploratory study found after looking at data from the first two U.S. states to end cannabis prohibition.

The Federal Trade Commission (FTC) sent letters on Tuesday ordering three companies to stop making unfounded health claims about their CBD products. “It is illegal to advertise that a product can prevent, treat, or cure human disease without competent and reliable scientific evidence to support such claims,” FTC said in a press release about the action.

Lesotho now Africa’s medical cannabis pioneer. Cannabis – referred here as ‘green gold’ – is grown legally by the Lesotho-based company Medigrow and is regulated by the government

New Zealand’s Helen Clark backs letting ex-criminals sell cannabis legally. “They’ve got the experience of growing it,” the former Prime Minister told Newshub Nation on Saturday.New Zealand’s Helen Clark backs letting ex-criminals sell cannabis legally.

Colombia Is Turning Into A Major Medical Marijuana Producer. Patricia Santiago and her family were forced to flee their home near Colombia’s Caribbean coast after complaining about neighborhood dope dealers who, in turn, threatened to kill them. But in an odd twist, Santiago now works in the drug trade — at a medical marijuana facility.Colombia Is Turning Into A Major Medical Marijuana Producer.

Medical cannabis in Paraguay: MSPyBS opens process to grant licenses. Minister of Health announced the beginning of the process for licensing for its production, industrialization and controlled commercialization.Applications from interested companies will be received from October 1 to 31, at the National Health Surveillance Directorate.

The fumette is invited to Palais Bourbon. While an experimentation of therapeutic cannabis in France has just been authorized at the beginning of the summer by the Agence du médicament, the National Assembly is seizing for the first time so widely, this highly controversial subject. 

As Shares Wilt, Israeli Cannabis Firms Cling to Dreams. Big four working to develop markets in Europe, China and India, make deals and fund research and development

Medical cannabis awaits a legal framework to take root in Spain. A company plans to market the flower of the plant before the end of the year and the industrial product in 2020

The Drug Enforcement Agency has unveiled plans to increase the amount of marijuana legally produced for research purposes in the U.S. by 30% in 2020. This year’s cannabis quota is 2,450 kg and the DEA aims to increase that to 3,200 kg next year to allow more vital research to take place. It follows the Agency’s pledge last month to ramp up the number of marijuana growers who are federally authorized to conduct cannabis research.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.